John Mertens

Medical Imaging
Emeritus, Vriendenkring VUB

Pleinlaan2
1050 Brussel
Belgium
Pleinlaan 2
1050 Brussels
Belgium

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise

Analysis of minor and trace elements in various matrices (biological material, foodstuff) using XRF, NAA, PIXE. Qualitative and quantitative analysis of radioactive contaminations with alpha, beta or gamma emitters. Absolute efficiency calibration of scintillation and proportional flow-through detectors for gaseous beta-emitters. Various qualitative and quantitative chemical analysis using HPLC, GCMS, IR and UV spectrometry. Irradiation of small laboratory animals and objects with calibrated gama sources. Irradiations with charged particle beams (protons, alpha, deuterons). Study and automatisation of separation and purification techniques for radioisotopes.
Development of radioactive molecules for molecular imaging and radionuclide therapy. Synthesis of precursor molecules. Optimization of the Radiosynthesis Methods with Radiohalogens (123I,131I,125I18F) and Radiometals (111In 3+,201Tl 3+,99mTc(III) and (V), 99mTc1+ - tricarbonyl). New radioiodination and radiobromination procedures applied in radiopharmaceutical industry (patent). Development of new radioactive compounds for diagnosis with SPECT and PET (brain receptors, brain tumors, tumours of periphery )( 4 patents). In vitro evaluation in cell models (over)expressing transporters and/or receptors. In vivo evaluation in rodent models (nude mice with tumours, rats with or without tumours) by means of (animal) SPECT and PET and dissection. European Project ( with Organic Chemistry VUBrussel, PSI Switserland, FZRossendorf Germany, Democritos Center Athene) on Radiometallo- chelated (111In, 201Tl, 99mTc,..) peptides as potential tumor tracers. Eureka project with University Zurich and Mallinckrodt Medi

Fingerprint

Dive into the research topics where John Mertens is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

1 Active
11 Finished

AII50: The Optimal (18F)-labeled Fluoroalkyl-phenylalanine analogue for Tumour Specific Diagnosis with PET-Structure-Activity Relation study of (18F)-Labeled Fluoroalkyl-L and D-Phenylalanine.
Mertens, J.
12/01/09 → …
Project: Fundamental
OZR1715: Development of positron emission tomography technologies for cancer diagnosis and new drugs development
Tavernier, S., Bossuyt, A., Bruyndonckx, P., Defrise, M. & Mertens, J.
1/01/08 → 31/12/08
Project: Fundamental
ADSI15: Interne overschrijving voor uitbetaling doctoraatsbeurs.
Mertens, J.
1/01/04 → 31/12/04
Project: Fundamental
FWOAL281: Development of L-and D- 18F-alkyl - phenylalanine and 18F-leucine analogues as tumor-specific PET tracers.
Bossuyt, A. & Mertens, J.
1/01/04 → 31/12/07
Project: Fundamental
ADSI2: IIRC-FWO project met Prof. G. SLEGERS (UGent).
Mertens, J.
1/01/04 → 31/12/07
Project: Fundamental

959 Citations
17 h-Index
75 Article
8 Editorial
7 Conference paper
5 Meeting abstract (Book)
More

Establishment of a Kinetic Model for the Intramolecular Catalyzed Hydrolysis of [18 F]- Benzylfluoride Containing Amino Acid Analoques by Linking Experimental and DFT Studies
Kersemans, K., Sablon, N., Geerlings, P. & Mertens, J., 2012, In : Intern. J. Chem. Kin.. 44, p. 705 1 p.
Research output: Contribution to journal › Article
2 Citations (Scopus)
Mechanistic approach of the difference in hydrolysis rate between the 2- and 4-isomers of no-carrier added [18F] fluoromethyl-L-phenylalanine
Kersemans, K., Mertens, J., De Proft, F. & Geerlings, P., 2011, In : Journal of Labelled Compounds and Radiopharmaceuticals. 54, p. 220 1 p.
Research output: Contribution to journal › Article
3 Citations (Scopus)
Mechanistic approach of the difference in non-enzymatic hydrolysis rate between the L and D enantiomers of no-carrier added 2-[18F] fluoromethyl-phenylalanine
Kersemans, K., Mertens, J., De Proft, F. & Geerlings, P., 2011, In : Journal of Labelled Compounds and Radiopharmaceuticals. 54, p. 80 1 p.
Research output: Contribution to journal › Article
2 Citations (Scopus)
The impact of HF-rTMS treatment on serotonin(2A) receptors in unipolar melancholic depression
Baeken, C., De Raedt, R., Bossuyt, A., Vanhove, C., Mertens, J., Dobbeleir, A., Blanckaert, P. & Goethals, L., Apr 2011, In : Brain Stimulation. 4, p. 104-111 8 p.
Research output: Contribution to journal › Article
53 Citations (Scopus)
The impact of HF-rTMS treatment on Serotonin 2A receptors in unipolar melancholic depression
Baeken, C., De Raedt, R., Bossuyt, A., Van Hove, C., Mertens, J., Dobbeleir, A., Blanckaert, P. & Goethals, I., 2011, In : Brain Stimul. 4, 2, p. 104-111 8 p.
Research output: Contribution to journal › Article

Mallinckrodt Award
John Mertens (Recipient), 1989
Prize: Prize (including medals and awards)
Prijs Stas van de Belgische Academie Wetenschappen
John Mertens (Recipient), 1997
Prize: Prize (including medals and awards)

8 Membership of external research organisation
1 Consultancy
1 Research and Teaching at External Organisation

Unknown (External organisation)
John Mertens (Member)
1 Jan 2004 → 31 Dec 2007
Activity: Membership › Membership of external research organisation
Unknown (External organisation)
John Mertens (Member)
1 Jan 2004 → 31 Dec 2007
Activity: Membership › Membership of external research organisation
Unknown (External organisation)
John Mertens (Member)
1 Jan 2004 → 30 Sep 2006
Activity: Membership › Membership of external research organisation
University of Zurich (External organisation)
John Mertens (Member)
1 Jan 2003 → …
Activity: Membership › Membership of external research organisation
European Association for Nuclear Medicine (External organisation)
John Mertens (Member)
1 Jan 2002 → 31 Dec 2002
Activity: Membership › Membership of external research organisation

"Development of new radiofluorinated methylphenylalanine analoques for tumour imaging with PET".
Author: Kersemans, K., Geerlings, P. & Mertens, J., 21 Jan 2011
Supervisor: Geerlings, P. (Promotor) & Mertens, J. (Co-promotor)
Student thesis: Doctoral Thesis
Human biodistribution studies: acritical step int he clinical evaluation of new radiopharmaceutical drugs
Author: Caveliers, V., Bossuyt, A., Michotte, Y., Smolders, I. J., Vander Heyden, Y., Thornback, J., Mertens, J., Slegers, G. & Foriers, A., 19 Mar 2003
Supervisor: Bossuyt, A. (Promotor), Michotte, Y. (Co-promotor), Smolders, I. (Jury), Vander Heyden, Y. (Jury), Mertens, J. (Jury), Foriers, A. (Jury), Thornback, J. (External person) (Jury) & Slegers, G. (External person) (Jury)
Student thesis: Doctoral Thesis
Human biodistribution studies: a critical step in the clinical evaluation of radiopharmaceutical drugs.
Author: Caveliers, V., Bossuyt, A., Foriers, A., Michotte, Y., Thornback, J., Slegers, G., Mertens, J., Smolders, I. J. & Vander Heyden, Y., 2006
Supervisor: Bossuyt, A. (Promotor), Foriers, A. (Jury), Michotte, Y. (Co-promotor), Mertens, J. (Jury), Smolders, I. (Jury), Vander Heyden, Y. (Jury), Thornback, J. (External person) (Jury) & Slegers, G. (External person) (Jury)
Student thesis: Doctoral Thesis
In Vivo Bioluminescentie in de studie van het potentieel radiotherapeutisch effect van 131I-2-Iodo-D-phenylalanine in de tumormuis
Author: Wimana, L., Mertens, J. & Lahoutte, T., 27 Jun 2008
Supervisor: Mertens, J. (Promotor) & Lahoutte, T. (Co-promotor)
Student thesis: Master-after-master
Radioiodinated D aromatic amino acid analogues as potential cancer theragnostics
Author: Bauwens, M., Mertens, J., Lahoutte, T., Van Schravendijk, C., Everaert, H., Neyns, B., Smolders, I., De Jong, M., De Vos, F. & Verbruggen, A., 5 Mar 2009
Supervisor: Mertens, J. (Promotor), Lahoutte, T. (Co-promotor), Van Schravendijk, C. (Jury), Everaert, H. (Jury), Neyns, B. (Jury), Smolders, I. (Jury), De Jong, M. (External person) (Jury), De Vos, F. (External person) (Jury) & Verbruggen, A. (External person) (Jury)
Student thesis: Doctoral Thesis